首页 产品中心
  • URMC-099
  • 货号: abs817722
    CAS号: 1229582-33-5
    分子式: C27H27N5
    分子量: 421.54
    产品说明书
    分享:
    货号-规格 货期 价格 数量
    abs817722-2mg 1-2周 ¥987.00
    - +
    abs817722-5mg 1-2周 ¥1143.00
    - +
    abs817722-10mg 1-2周 ¥1733.00
    - +
    abs817722-25mg 1-2周 ¥3633.00
    - +
    大包装询价
    产品描述
    描述

    URMC-099 is an orally bioavailable, brain penetrant mixed lineage kinase (MLK) inhibitor with IC50 of 19 nM, 42 nM, 14 nM, and 150 nM, for MLK1, MLK2, MLK3, and DLK, respectively, and also inhibits LRRK2 activity with IC50 of 11 nM.

    纯度
    98%
    储存/保存方法
    store at -20℃ for one year(Powder);
    in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months.
    基本信息
    可溶性/溶解性
    Ethanol ;6 mg/mL (14.2 mM)

    DMSO :75 mg/mL (177.9 mM)
    生物活性
    靶点
    Abl1 ,LRRK2 ,MLK3 ,MLK1 ,VEGFR1/FLT1
    In vitro(体外研究)
    URMC-099 inhibits LPS-induced TNFα release in microglial cells, and HIV-1 Tat-induced release of cytokines in human monocytes. URMC-099 prevents destruction and phagocytosis of cultured neuronal axons by microglia cells. URMC-099 reduces fMLP-induced chemotaxis of wild-type neutrophil in vitro.
    In vivo(体内研究)
    In mice, URMC-099 shows excellent pharmacokinetic properties and improved CNS penetration. In vivo, URMC-099 (10 mg/kg i.p.) reduces inflammatory cytokine production, protects neuronal architecture, and alters the morphologic and ultrastructural response of microglia to HIV-1 Tat exposure. URMC099 significantly reduces recruitment of neutrophils into the peritoneum by fMLP in wild-type mice.
    参考文献
    参考文献
    温馨提示:本产品仅作科研实验使用,不支持临床等研究
        提示: 尊敬的客户您好,如果您对我们的产品有什么疑问或想要了解的,可以点击“我要提问”按钮填写您的疑问。
        提交不成功?请联系info@absin.cn。
        我要提问

    促销资讯 更多

      订购信息
      您可以从我们的授权经销商处购买absin产品或获得技术支持。若要查看您所在地区的经销商,请从以下的下拉列表中选择。
      GO
      • 0